75 related articles for article (PubMed ID: 21370050)
1. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes.
Chiu YL
Methods Mol Biol; 2011; 718():185-206. PubMed ID: 21370050
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G: an intracellular centurion.
Chiu YL; Greene WC
Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):689-703. PubMed ID: 19008196
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.
Stopak KS; Chiu YL; Kropp J; Grant RM; Greene WC
J Biol Chem; 2007 Feb; 282(6):3539-46. PubMed ID: 17110377
[TBL] [Abstract][Full Text] [Related]
5. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
Soros VB; Yonemoto W; Greene WC
PLoS Pathog; 2007 Feb; 3(2):e15. PubMed ID: 17291161
[TBL] [Abstract][Full Text] [Related]
6. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
[TBL] [Abstract][Full Text] [Related]
7. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
[TBL] [Abstract][Full Text] [Related]
8. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
9. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
[TBL] [Abstract][Full Text] [Related]
10. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Friew YN; Boyko V; Hu WS; Pathak VK
Retrovirology; 2009 Jun; 6():56. PubMed ID: 19497112
[TBL] [Abstract][Full Text] [Related]
11. The roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.
Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
PLoS One; 2013; 8(10):e74892. PubMed ID: 24098356
[TBL] [Abstract][Full Text] [Related]
12. The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity.
Pido-Lopez J; Wang Y; Seidl T; Babaahmady K; Vaughan R; Lehner T
Eur J Immunol; 2009 Jul; 39(7):1956-65. PubMed ID: 19585516
[TBL] [Abstract][Full Text] [Related]
13. The cellular source for APOBEC3G's incorporation into HIV-1.
Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
Retrovirology; 2011 Jan; 8():2. PubMed ID: 21211018
[TBL] [Abstract][Full Text] [Related]
14. Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.
Oliva H; Pacheco R; Martinez-Navio JM; Rodríguez-García M; Naranjo-Gómez M; Climent N; Prado C; Gil C; Plana M; García F; Miró JM; Franco R; Borras FE; Navaratnam N; Gatell JM; Gallart T
Immunol Cell Biol; 2016 Aug; 94(7):689-700. PubMed ID: 26987686
[TBL] [Abstract][Full Text] [Related]
15. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.
Trapp S; Derby NR; Singer R; Shaw A; Williams VG; Turville SG; Bess JW; Lifson JD; Robbiani M
J Virol; 2009 Jan; 83(2):884-95. PubMed ID: 19004943
[TBL] [Abstract][Full Text] [Related]
16. Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.
Rose KM; Marin M; Kozak SL; Kabat D
AIDS Res Hum Retroviruses; 2005 Jul; 21(7):611-9. PubMed ID: 16060832
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.
McDougall WM; Smith HC
Biochem Biophys Res Commun; 2011 Sep; 412(4):612-7. PubMed ID: 21856286
[TBL] [Abstract][Full Text] [Related]
18. Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits.
Wedekind JE; Gillilan R; Janda A; Krucinska J; Salter JD; Bennett RP; Raina J; Smith HC
J Biol Chem; 2006 Dec; 281(50):38122-6. PubMed ID: 17079235
[TBL] [Abstract][Full Text] [Related]
19. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.
Thielen BK; Klein KC; Walker LW; Rieck M; Buckner JH; Tomblingson GW; Lingappa JR
PLoS Pathog; 2007 Sep; 3(9):1320-34. PubMed ID: 17892323
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
Khatua AK; Taylor HE; Hildreth JE; Popik W
Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
